Tom Lillie

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Robert E. Smith, Matti Aapro, Heinz Ludwig et al. · Journal of Clinical Oncology · 2008 · 212 citations · Full text

Medicine, Oncology, Pharmacology +10

Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus Etoposide

Robert Pirker, Rodryg Ramlau, Wolfgang Schuette et al. · Journal of Clinical Oncology · 2008 · 115 citations

Medicine, Oncology, Pharmacology +12

Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)

Marwan Fakih, Wael A. Harb, Daruka Mahadevan et al. · Journal for ImmunoTherapy of Cancer · 2023 · 47 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced Anemia

Ralph V. Boccia, Imtiaz A. Malik, Vinay Raja et al. · The Oncologist · 2006 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +9

Treating Anemia of Cancer with Every-4-Week Darbepoetin Alfa: Final Efficacy and Safety Results from a Phase II, Randomized, Double-Blind, Placebo-Controlled Study

David Gordon, Gwen Nichols, A. Ben-Jacob et al. · The Oncologist · 2008 · 24 citations

Medicine, Hematology, Pharmacology +14